+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07788846

Comparing Hemocoll FTC, Avitene MCH, and Bone Wax for Controlling Bleeding After Single-Ray Amputation

Led by Adichunchanagiri Institute of Medical Sciences, B G Nagara · Updated on 2026-10-27

135

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter, prospective, randomized controlled trial to compare three types of haemostatic materialsHemocoll fibrillar Type-I collagen haemostat FTC, Avitene Microfibrillar Collagen Hemostat MCH, and conventional bone wax. The trial focuses on controlling bleeding from exposed cancellous bone in adults undergoing planned single-ray amputation involving phalangeal, metacarpal, or metatarsal bones. The main goal is to evaluate which material best achieves complete haemostasis at specific times after application, with Hemocoll FTC and Avitene MCH being directly compared primarily. Participants are randomly assigned to receive one of the three haemostatic materials applied directly to the exposed cancellous bone surface after the amputation, tourniquet release, and standardized soft-tissue haemostasis. A common compression method using sterile gauze and elastic crepe bandage is applied for 60 seconds across all groups. The primary haemostasis assessment times vary by anatomical site 2 minutes for phalanx, 3 minutes for metacarpal, and 5 minutes for metatarsal bones. Secondary comparisons include evaluating Hemocoll FTC versus bone wax and Avitene MCH versus bone wax. During the trial, participants will be monitored for haemostasis success, bleeding grades, time to haemostasis, and possible complications such as rebleeding or wound issues. Surgeons will also assess ease of application and material use. The study includes intraoperative assessments and follows participants for postoperative bleeding, hematoma, and adverse events related to the materials. The study plans to enroll 135 adults and expects to complete by January 2027.

CONDITIONS

Brief Title

Hemocoll, Avitene, or Bone Wax for Cancellous Bone Bleeding After Single-Ray Amputation

Research Team

N

Naveen Narayan, MS, MCh

C

Chethan Shivannaiah, DNB

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here